Does PALBOCICLIB Cause Dyspepsia? 795 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 795 reports of Dyspepsia have been filed in association with PALBOCICLIB (Ibrance). This represents 0.9% of all adverse event reports for PALBOCICLIB.
795
Reports of Dyspepsia with PALBOCICLIB
0.9%
of all PALBOCICLIB reports
22
Deaths
107
Hospitalizations
How Dangerous Is Dyspepsia From PALBOCICLIB?
Of the 795 reports, 22 (2.8%) resulted in death, 107 (13.5%) required hospitalization, and 12 (1.5%) were considered life-threatening.
Is Dyspepsia Listed in the Official Label?
Yes, Dyspepsia is listed as a known adverse reaction in the official FDA drug label for PALBOCICLIB.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Dyspepsia?
ADALIMUMAB (3,586)
METHOTREXATE (2,690)
RITUXIMAB (2,289)
TOFACITINIB (2,264)
PREDNISONE (2,224)
APREMILAST (2,207)
ETANERCEPT (2,100)
ESOMEPRAZOLE (2,064)
TOCILIZUMAB (2,046)
LEFLUNOMIDE (1,981)
Which PALBOCICLIB Alternatives Have Lower Dyspepsia Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID